Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FQ1F4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,935
Award facts
- Contract value 100% obligated
- $15,934.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,934.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This non-set-aside contract represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle that runs through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. Dupixent is a prescription medication used to treat conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis, making this order consistent with the Defense Health Agency's medical supply requirements.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated capability to meet competitive procurement requirements across a broad spectrum of therapeutic categories. This delivery order exemplifies the company's role in supporting military healthcare programs through the DLA's pharmaceutical prime vendor network, which supplies medications and medical commodities to military installations and the Defense Health Agency worldwide. The firm fixed-price structure and expedited completion timeline reflect the urgent nature of medical supply fulfillment within the federal healthcare system.
Quick answers
Who was awarded contract SPE2DB25FQ1F4?
SPE2DB25FQ1F4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FQ1F4 worth?
The government has obligated $15,935 on SPE2DB25FQ1F4.
Is contract SPE2DB25FQ1F4 an order under another contract?
Yes. SPE2DB25FQ1F4 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ1F4 competed?
The extent of competition for SPE2DB25FQ1F4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award